Modulation of infection-mediated migration of neutrophils and CXCR2 trafficking by osteopontin

Immunology

Volumn 150, Issue 1, 2017, Pages 74-86

  Singh, Rani ^a,b   Hui, Tommy ^a   Matsui, Aritsune ^a,c   Allahem, Ziyad ^a,d   Johnston, Christopher D ^a,b   Ruiz Torruella, Montserrat ^a   Rittling, Susan R ^a,b  

^a FORSYTH INSTITUTE   (United States)

^b HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^c TOHOKU UNIVERSITY   (Japan)

^d KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

CXCR2; endodontic infection; integrin v; osteopontin; receptor recycling

Indexed keywords

CHEMOKINE RECEPTOR CXCR2; CXCL1 CHEMOKINE; OSTEOPONTIN; ALPHA5 INTEGRIN;

AIR POUCH; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL LOAD; BIOACCUMULATION; CELL MIGRATION; CELL SURFACE; CONTROLLED STUDY; INFECTION; INNATE IMMUNITY; MOUSE; NEUTROPHIL; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; 129 MOUSE; ANIMAL; BACTERIAL INFECTION; C57BL MOUSE; CELL MOTION; DISEASE MODEL; GENETICS; HUMAN; IMMUNOLOGY; KNOCKOUT MOUSE; MALE; METABOLISM; PULPITIS;

ANIMALS; BACTERIAL INFECTIONS; BACTERIAL LOAD; CELL MOVEMENT; CHEMOKINE CXCL1; DISEASE MODELS, ANIMAL; HUMANS; IMMUNITY, INNATE; INTEGRIN ALPHA5; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; NEUTROPHILS; OSTEOPONTIN; PULPITIS; RECEPTORS, INTERLEUKIN-8B;

EID: 84990975271     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/imm.12668     Document Type: Article

References (58)

1. Figdor D. Apical periodontitis: a very prevalent problem. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002; 94:651–2.
2. Zehnder M, Belibasakis GN. On the dynamics of root canal infections – what we understand and what we don't. Virulence 2015; 6:216–22.
3. Siqueira JF Jr, Rocas IN. Diversity of endodontic microbiota revisited. J Dent Res 2009; 88:969–81.
4. Sasaki H, Hou L, Belani A, Wang CY, Uchiyama T, Muller R et al. IL-10, but not IL-4, suppresses infection-stimulated bone resorption in vivo. J Immunol 2000; 165:3626–30.
5. Balto K, Sasaki H, Stashenko P. Interleukin-6 deficiency increases inflammatory bone destruction. Infect Immun 2001; 69:744–50.
6. Okamatsu Y, Kim D, Battaglino R, Sasaki H, Spate U, Stashenko P. MIP-1γ promotes receptor-activator-of-NF-κB-ligand-induced osteoclast formation and survival. J Immunol 2004; 173:2084–90.
7. Sasaki H, Balto K, Kawashima N, Eastcott J, Hoshino K, Akira S et al. Gamma interferon (IFN-γ) and IFN-γ-inducing cytokines interleukin-12 (IL-12) and IL-18 do not augment infection-stimulated bone resorption in vivo. Clin Diagn Lab Immunol 2004; 11:106–10.
8. AlShwaimi E, Berggreen E, Furusho H, Rossall JC, Dobeck J, Yoganathan S et al. IL-17 receptor A signaling is protective in infection-stimulated periapical bone destruction. J Immunol 2013; 191:1785–91.
9. Rittling SR, Zetterberg C, Yagiz K, Skinner S, Suzuki N, Fujimura A et al. Protective role of osteopontin in endodontic infection. Immunology 2010; 129:105–14.
10. Dale DC, Boxer L, Liles WC. The phagocytes: neutrophils and monocytes. Blood 2008; 112:935–45.
11. Kawashima N, Niederman R, Hynes RO, Ullmann-Cullere M, Stashenko P. Infection-stimulated infraosseus inflammation and bone destruction is increased in P-/E-selectin knockout mice. Immunology 1999; 97:117–23.
12. Matsui A, Jin JO, Johnston CD, Yamazaki H, Houri-Haddad Y, Rittling SR. Pathogenic bacterial species associated with endodontic infection evade innate immune control by disabling neutrophils. Infect Immun 2014; 82:4068–79.
13. Lin F, Nguyen CM, Wang SJ, Saadi W, Gross SP, Jeon NL. Effective neutrophil chemotaxis is strongly influenced by mean IL-8 concentration. Biochem Biophys Res Commun 2004; 319:576–81.
14. Bizzarri C, Beccari AR, Bertini R, Cavicchia MR, Giorgini S, Allegretti M. ELR+ CXC chemokines and their receptors (CXC chemokine receptor 1 and CXC chemokine receptor 2) as new therapeutic targets. Pharmacol Ther 2006; 112:139–49.
15. Yu JJ, Ruddy MJ, Wong GC, Sfintescu C, Baker PJ, Smith JB et al. An essential role for IL-17 in preventing pathogen-initiated bone destruction: recruitment of neutrophils to inflamed bone requires IL-17 receptor-dependent signals. Blood 2007; 109:3794–802.
16. Khan S, Cole N, Hume EB, Garthwaite L, Conibear TC, Miles DH et al. The role of CXC chemokine receptor 2 in Pseudomonas aeruginosa corneal infection. J Leukoc Biol 2007; 81:315–8.
17. Herbold W, Maus R, Hahn I, Ding N, Srivastava M, Christman JW et al. Importance of CXC chemokine receptor 2 in alveolar neutrophil and exudate macrophage recruitment in response to pneumococcal lung infection. Infect Immun 2010; 78:2620–30.
18. Matsui A, Stephens D, Kantarci A, Rittling SR. Early cytokine response to infection with pathogenic vs non-pathogenic organisms in a mouse model of endodontic infection. PLoS ONE 2015; 10:e0132752.
19. Rittling SR. Osteopontin in macrophage function. Expert Rev Mol Med 2011; 13:e15.
20. Uede T. Osteopontin, intrinsic tissue regulator of intractable inflammatory diseases. Pathol Int 2011; 61:265–80.
21. van der Windt GJ, Hoogerwerf JJ, de Vos AF, Florquin S, van der Poll T. Osteopontin promotes host defense during Klebsiella pneumoniae-induced pneumonia. Eur Respir J 2010; 36:1337–45.
22. Inoue M, Williams KL, Gunn MD, Shinohara ML. NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A 2012; 109:10480–5.
23. Lund SA, Wilson CL, Raines EW, Tang J, Giachelli CM, Scatena M. Osteopontin mediates macrophage chemotaxis via α4 and α9 integrins and survival via the α4 integrin. J Cell Biochem 2013; 114:1194–202.
24. Rittling SR, Singh R. Osteopontin in immune-mediated diseases. J Dent Res 2015; 94:1638–45.
25. Koh A, da Silva AP, Bansal AK, Bansal M, Sun C, Lee H et al. Role of osteopontin in neutrophil function. Immunology 2007; 122:466–75.
26. Barreno RX, Richards JB, Schneider DJ, Cromar KR, Nadas AJ, Hernandez CB et al. Endogenous osteopontin promotes ozone-induced neutrophil recruitment to the lungs and airway hyperresponsiveness to methacholine. Am J Physiol Lung Cell Mol Physiol 2013; 305:L118–29.
27. Rittling SR, Matsumoto HN, McKee MD, Nanci A, An XR, Novick KE et al. Mice lacking osteopontin show normal development and bone structure but display altered osteoclast formation in vitro. J Bone Miner Res 1998; 13:1101–11.
28. Chen Y, Rittling SR. Novel murine mammary epithelial cell lines that form osteolytic bone metastases: effect of strain background on tumor homing. Clin Exp Metastasis 2003; 20:111–20.
29. Lacy-Hulbert A, Smith AM, Tissire H, Barry M, Crowley D, Bronson RT et al. Ulcerative colitis and autoimmunity induced by loss of myeloid αv integrins. Proc Natl Acad Sci USA 2007; 104:15823–8.
30. Swamydas M, Lionakis MS. Isolation, purification and labeling of mouse bone marrow neutrophils for functional studies and adoptive transfer experiments. J Vis Exp 2013; 77:e50586.
31. + T cells is dependent on integrin αV. Nat Immunol 2013; 14:949–58.
32. Kazanecki CC, Kowalski AJ, Ding T, Rittling SR, Denhardt DT. Characterization of anti-osteopontin monoclonal antibodies: binding sensitivity to post-translational modifications. J Cell Biochem 2007; 102:925–35.
33. Rittling SR, Feng F. Detection of mouse osteopontin by western blotting. Biochem Biophys Res Commun 1998; 250:287–92.
34. Colville-Nash P, Lawrence T. Air-pouch models of inflammation and modifications for the study of granuloma-mediated cartilage degradation. Methods Mol Biol 2003; 225:181–9.
35. Sharif SA, Du X, Myles T, Song JJ, Price E, Lee DM et al. Thrombin-activatable carboxypeptidase B cleavage of osteopontin regulates neutrophil survival and synoviocyte binding in rheumatoid arthritis. Arthritis Rheum 2009; 60:2902–12.
36. Kobayashi Y. Neutrophil infiltration and chemokines. Crit Rev Immunol 2006; 26:307–16.
37. Nishimichi N, Higashikawa F, Kinoh HH, Tateishi Y, Matsuda H, Yokosaki Y. Polymeric osteopontin employs integrin α9β1 as a receptor and attracts neutrophils by presenting a de novo binding site. J Biol Chem 2009; 284:14769–76.
38. Caswell PT, Chan M, Lindsay AJ, McCaffrey MW, Boettiger D, Norman JC. Rab-coupling protein coordinates recycling of α5β1 integrin and EGFR1 to promote cell migration in 3D microenvironments. J Cell Biol 2008; 183:143–55.
39. Banerjee A, Apte UM, Smith R, Ramaiah SK. Higher neutrophil infiltration mediated by osteopontin is a likely contributing factor to the increased susceptibility of females to alcoholic liver disease. J Pathol 2006; 208:473–85.
40. Uaesoontrachoon K, Wasgewatte Wijesinghe DK, Mackie EJ, Pagel CN. Osteopontin deficiency delays inflammatory infiltration and the onset of muscle regeneration in a mouse model of muscle injury. Dis Model Mech 2013; 6:197–205.
41. Hirano Y, Aziz M, Yang WL, Wang Z, Zhou M, Ochani M et al. Neutralization of osteopontin attenuates neutrophil migration in sepsis-induced acute lung injury. Crit Care 2015; 19:53.
42. van der Windt GJ, Hoogendijk AJ, Schouten M, Hommes TJ, de Vos AF, Florquin S et al. Osteopontin impairs host defense during pneumococcal pneumonia. J Infect Dis 2011; 203:1850–8.
43. Rittling SR, Singh R. Osteopontin in immune-mediated diseases. J Dent Res 2015; 94:1638–45.
44. Wright HL, Moots RJ, Edwards SW. The multifactorial role of neutrophils in rheumatoid arthritis. Nat Rev Rheumatol 2014; 10:593–601.
45. Apte UM, Banerjee A, McRee R, Wellberg E, Ramaiah SK. Role of osteopontin in hepatic neutrophil infiltration during alcoholic steatohepatitis. Toxicol Appl Pharmacol 2005; 207:25–38.
46. Hu DD, Hoyer JR, Smith JW. Calcium suppresses cell adhesion to osteopontin by attenuating binding affinity for integrin αvβ3. J Biol Chem 1995; 270:9917–25.
47. Taooka Y, Chen J, Yednock T, Sheppard D. The integrin α9β1 mediates adhesion to activated endothelial cells and transendothelial neutrophil migration through interaction with vascular cell adhesion molecule-1. J Cell Biol 1999; 145:413–20.
48. 1 binds to a novel recognition sequence (SVVYGLR) in the thrombin-cleaved amino-terminal fragment of osteopontin. J Biol Chem 1999; 274:36328–34.
49. Chigaev A, Sklar LA. Aspects of VLA-4 and LFA-1 regulation that may contribute to rolling and firm adhesion. Front Immunol 2012; 3:242.
50. Hui T, Sorensen ES, Rittling SR. Osteopontin binding to the alpha 4 integrin requires highest affinity integrin conformation, but is independent of post-translational modifications of osteopontin. Matrix Biol 2015; 41:19–25.
51. Tye CE, Baybayan L, Gordon JAR, Ball E, Hunter GK, Goldberg HA. Bone Sialoprotein Interaction with Type I Collagen. 8th International Conference on the Chemistry and Biology of Mineralized Tissues, 2004: 132–4.
52. Rittling SR, Chen Y, Feng F, Wu Y. Tumor-derived osteopontin is soluble, not matrix associated. J Biol Chem 2002; 277:9175–82.
53. De Franceschi N, Hamidi H, Alanko J, Sahgal P, Ivaska J. Integrin traffic – the update. J Cell Sci 2015; 128:839–52.
54. White JR, Lee JM, Young PR, Hertzberg RP, Jurewicz AJ, Chaikin MA et al. Identification of a potent, selective non-peptide CXCR2 antagonist that inhibits interleukin-8-induced neutrophil migration. J Biol Chem 1998; 273:10095–8.
55. Raghuwanshi SK, Su Y, Singh V, Haynes K, Richmond A, Richardson RM. The chemokine receptors CXCR1 and CXCR2 couple to distinct G protein-coupled receptor kinases to mediate and regulate leukocyte functions. J Immunol 2012; 189:2824–32.
56. Singh V, Raghuwanshi SK, Smith N, Rivers EJ, Richardson RM. G Protein-coupled receptor kinase-6 interacts with activator of G protein signaling-3 to regulate CXCR2-mediated cellular functions. J Immunol 2014; 192:2186–94.
57. Marchese A. Endocytic trafficking of chemokine receptors. Curr Opin Cell Biol 2014; 27:72–7.
58. Jacquemet G, Humphries MJ, Caswell PT. Role of adhesion receptor trafficking in 3D cell migration. Curr Opin Cell Biol 2013; 25:627–32.